EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
0 hedge funds and large institutions have $0 invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EC
1
EcoR1 Capital
San Francisco,
California
| – | -$2.03M | -200,000 | Closed |
|
|
SIA
2
SkyView Investment Advisors
Shrewsbury,
New Jersey
| – | -$728K | -71,773 | Closed |
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$222K | -21,923 | Closed |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| – | -$7K | -647 | Closed |
|